PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
6.39
+0.04 (0.63%)
At close: May 22, 2026, 4:00 PM EDT
6.26
-0.13 (-2.03%)
After-hours: May 22, 2026, 7:47 PM EDT

PAVmed Stock Forecast

PAVM's stock price has decreased by -66.2% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 analysts polled by S&P Global, PAVmed stock has a consensus rating of "Buy" and an average price target of $40.5. The average 1-year stock price forecast is 533.80% higher than the current stock price, while the lowest is $16 (+150.39%) and the highest is $65 (+917.21%).

Price Target: $40.5 (+533.80%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$16$40.5$40.5$65
Change+150.39%+533.80%+533.80%+917.21%
* Price targets were last updated on Apr 9, 2026.

Analyst Ratings

The average analyst rating for PAVmed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy111111
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$510$65
Strong BuyMaintains$510$65+917.21%Apr 9, 2026
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$600$510
Strong BuyMaintains$600$510+7,881.22%Dec 10, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$570$600
Strong BuyMaintains$570$600+9,289.67%Oct 6, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$585$570
Strong BuyMaintains$585$570+8,820.19%Jun 6, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$570$585
Strong BuyMaintains$570$585+9,054.93%Apr 21, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
499.80K
from 71.00K
Increased by 603.94%
Revenue Next Year
665.55K
from 499.80K
Increased by 33.16%
EPS This Year
-2.74
from -5.63
EPS Next Year
-1.79
from -2.74
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
500.00K377.00K2.45M3.00M71.00K499.80K665.55K
Revenue Growth
--24.60%550.40%22.15%-97.63%603.94%33.16%
EPS
-293.92-450.95-274.9214.90-5.63-2.74-1.79
EPS Growth
-------
Forward PE
-------
No. Analysts
-----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027
High525,000845,250
Avg499,800665,550
Low470,400490,000

Revenue Growth

Revenue Growth20262027
High
639.4%
69.1%
Avg
603.9%
33.2%
Low
562.5%
-2.0%

EPS Forecast

EPS20262027
High-2.82-1.84
Avg-2.74-1.79
Low-2.64-1.72

EPS Growth

EPS Growth20262027
High--
Avg--
Low--
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.